One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: Insights from Spanish multicenter registry

Journal of Interventional Cardiology

Volumn 24, Issue 6, 2011, Pages 518-528

  Vaquerizo, Beatriz ^a   Serra, Antonio ^a   Miranda Guardiola, Faustino ^a   Martínez, Vanesa ^b   Gómez Hospital, Joan Antoni ^b   Iñiguez, Andres ^c   Fernández, Eduardo ^d   Rumoroso, Jose Ramon ^e   Bosa, Francisco ^f   Otaegui, Imanol ^g  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL DE GALDAKAO   (Spain)

^f HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON; DIABETIC PATIENT; DRUG ELUTING BALLOON; FEMALE; HEART DEATH; HUMAN; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASPIRIN; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HEPARIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; REGISTRIES; SPAIN; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 83955164243     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00667.x     Document Type: Article

References (26)

1. Lemos PA, van Mieghem CA, Arampatzis CA, et al,. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: Late angiographic and clinical outcomes. Circulation 2004; 109: 2500-2502. (Pubitemid 38720546)
2. Camenzind E, Steg PG, Wijns W,. Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern. Circulation 2007; 115: 1440-1455. (Pubitemid 46648381)
3. Posa A, Hemetsberger R, Petnehazy O, et al,. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 2008; 19: 243-247.
4. Põsa Aniko, Nycolczas N, Hemetsberger R, et al,. Optimization of drug-eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheter Cardiovasc Interv 2010; 76: 395-403.
5. Fanggiday JC, Stella PR, Guyomi SH, et al,. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: The DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008; 71: 629-635. (Pubitemid 351559549)
6. Meliga E, Scheller B, Hehrlein C, et al,. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-2124. (Pubitemid 44749319)
7. Scheller B, Hehrlein C, Bocksch W, et al,. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008; 97: 773-781.
8. Unverdorben M, Vallbracht C, Cremers B, et al,. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009; 119: 2986-2994.
9. Mehran R, Dangas G, Abizaid AS, et al,. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878. (Pubitemid 29511140)
10. Cutlip DE, Windecker S, Mehran R, et al,. Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351. (Pubitemid 46685903)
11. Bauters C, Isner JM,. The biology of restenosis. In:, Topol EJ, Ed. Textbook of Cardiovascular Medicine. Philadelphia, PA: Lippincott-Raven, 1998, pp. 2465-2490.
12. Indolfi C, Coppola C, Torella D, et al,. Gene therapy for restenosis after balloon angioplasty and stenting. Cardiol Rev 1999; 7: 324-331.
13. Baz JA, Albarrán A, Pinar E, et al,. Spanish cardiac catheterization and coronary intervention registry. 18th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2008). Rev Esp Cardiol 2009; 62: 1418-1434.
14. Alfonso F,. Treatment of drug-eluting stent restenosis the new pilgrimage: Quo vadis? J Am Coll Cardiol 2010; 55: 2717-2720.
15. Kastrati A, Mehilli J, Von Beckerath N, et al,. ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005; 293: 165-171. (Pubitemid 40095867)
16. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, et al,. RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: Results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006; 47: 2152-2160. (Pubitemid 43795079)
17. Holmes DR Jr, Teirstein P, Satler L, et al,. SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trial. JAMA 2006; 295: 1264-1273.
18. Stone GW, Ellis SG, O'Shaughnessy CD, et al,. TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial. JAMA 2006; 295: 1253-1263.
19. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, et al,. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009; 103: 491-495.
20. Cosgrave J, Melzi G, Biondi-Zoccai GG, et al,. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol 2006; 47: 2399-2404. (Pubitemid 43866381)
21. Cosgrave J, Melzi G, Corbett S, et al,. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. Am Heart J 2007; 153: 354-359. (Pubitemid 46328767)
22. Fujii K, Mintz GS, Kobayashi Y, et al,. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088. (Pubitemid 38332610)
23. Gonzalo N, Serruys PW, Okamura T, et al,. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158: 284-293.
24. Mehilli J, Byrne RA, Tiroch K, et al,. ISAR-DESIRE 2 Investigators. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 2010; 55: 2710-2716.
25. Levisay JP, Price MJ, Shaba W, et al,. Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. J Invasive Cardiol 2010; 22: 216-219.
26. Habara S, Mitsudo K, Kadota K, et al,. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. J Am Coll Cardiol Interv 2011; 4: 149-154.